These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 20350367)

  • 1. PPARγ agonist rosiglitazone is neuroprotective after traumatic spinal cord injury via anti-inflammatory in adult rats.
    Zhang Q; Hu W; Meng B; Tang T
    Neurol Res; 2010 Oct; 32(8):852-9. PubMed ID: 20350367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiazolidinedione class of peroxisome proliferator-activated receptor gamma agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats.
    Park SW; Yi JH; Miranpuri G; Satriotomo I; Bowen K; Resnick DK; Vemuganti R
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1002-12. PubMed ID: 17167171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms.
    Yi JH; Park SW; Brooks N; Lang BT; Vemuganti R
    Brain Res; 2008 Dec; 1244():164-72. PubMed ID: 18948087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor-γ agonist rosiglitazone reduces secondary damage in experimental spinal cord injury.
    Li X; Du J; Xu S; Lin X; Ling Z
    J Int Med Res; 2013 Feb; 41(1):153-61. PubMed ID: 23569141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury.
    Genovese T; Esposito E; Mazzon E; Di Paola R; Muià C; Meli R; Bramanti P; Cuzzocrea S
    Shock; 2008 Aug; 30(2):142-52. PubMed ID: 18628687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative neuroprotective effects of methylprednisolone and rosiglitazone, a peroxisome proliferator-activated receptor-γ following spinal cord injury.
    Zhang Q; Huang C; Tang T; Shi Q; Yang H
    Neurosciences (Riyadh); 2011 Jan; 16(1):46-52. PubMed ID: 21206444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A peroxisome proliferator-activated receptor gamma agonist attenuates neurological deficits following spinal cord ischemia in rats.
    Kim H; Hwang J; Park S; Nahm SF; Min S; Lim C; Park K; Han S
    J Vasc Surg; 2014 Apr; 59(4):1084-9. PubMed ID: 23830318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosiglitazone attenuates inflammation and CA3 neuronal loss following traumatic brain injury in rats.
    Liu H; Rose ME; Culver S; Ma X; Dixon CE; Graham SH
    Biochem Biophys Res Commun; 2016 Apr; 472(4):648-55. PubMed ID: 26947332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 17beta-estradiol on signal transduction pathways and secondary damage in experimental spinal cord trauma.
    Cuzzocrea S; Genovese T; Mazzon E; Esposito E; Di Paola R; Muià C; Crisafulli C; Peli A; Bramanti P; Chaudry IH
    Shock; 2008 Mar; 29(3):362-71. PubMed ID: 17704735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents.
    Tureyen K; Kapadia R; Bowen KK; Satriotomo I; Liang J; Feinstein DL; Vemuganti R
    J Neurochem; 2007 Apr; 101(1):41-56. PubMed ID: 17394460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
    Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
    Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPAR-γ agonist rosiglitazone reduces autophagy and promotes functional recovery in experimental traumaticspinal cord injury.
    Li H; Zhang Q; Yang X; Wang L
    Neurosci Lett; 2017 May; 650():89-96. PubMed ID: 28433567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma.
    Paterniti I; Impellizzeri D; Crupi R; Morabito R; Campolo M; Esposito E; Cuzzocrea S
    J Neuroinflammation; 2013 Feb; 10():20. PubMed ID: 23374874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
    Luo Y; Yin W; Signore AP; Zhang F; Hong Z; Wang S; Graham SH; Chen J
    J Neurochem; 2006 Apr; 97(2):435-48. PubMed ID: 16539667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats.
    Sánchez-Hidalgo M; Martín AR; Villegas I; Alarcón De La Lastra C
    Biochem Pharmacol; 2005 Jun; 69(12):1733-44. PubMed ID: 15876425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats.
    Sánchez-Hidalgo M; Martín AR; Villegas I; de la Lastra CA
    Eur J Pharmacol; 2007 May; 562(3):247-58. PubMed ID: 17343846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosiglitazone exerts neuroprotective effects via the suppression of neuronal autophagy and apoptosis in the cortex following traumatic brain injury.
    Yao J; Zheng K; Zhang X
    Mol Med Rep; 2015 Nov; 12(5):6591-7. PubMed ID: 26351751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
    Lee EY; Lee JE; Park JH; Shin IC; Koh HC
    Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of the peroxisome proliferator-activated receptor (PPAR)-γ, ligand rosiglitazone on tert-butyl hydroperoxide-induced QZG cell injury.
    Li WL; Liang X; Wang X; Zhang XD; Liu R; Zhang W; Chen HL; Qin XJ; Bai H; Hai CX
    Exp Toxicol Pathol; 2011 Sep; 63(6):527-33. PubMed ID: 20510595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats.
    Bethea JR; Nagashima H; Acosta MC; Briceno C; Gomez F; Marcillo AE; Loor K; Green J; Dietrich WD
    J Neurotrauma; 1999 Oct; 16(10):851-63. PubMed ID: 10547095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.